When you think of the biggest centers in the world for medtech, places like Massachusetts and Minneapolis naturally come to mind. After all, that’s where many of the largest medical device companies—Boston Scientific, Medtronic, and St. Jude Medical, among them—are based. John Power hails from a completely different cluster. A native of London, Power built … Continue reading “An Entrepreneur Grows Along With Ireland’s Medtech Cluster: Galway”
Category: Boston
Inside Dublin’s Tech Startup Incubators: Dogpatch, Wayra, NDRC
Visit any major city in the world that claims to have a healthy tech startup community, and chances are it’s got at least one accelerator program or incubator space. The accelerator model that Silicon Valley-based Y Combinator made famous—providing seed money and mentorship to a new group of early-stage companies every few months, in exchange … Continue reading “Inside Dublin’s Tech Startup Incubators: Dogpatch, Wayra, NDRC”
CurrencyFair Rides Irish Fintech Wave With Money Transfer Market
These days, people can send a text message halfway around the world in a matter of seconds, but wiring money across the globe can still take several days. And the typically poor exchange rates and fees charged by banks and other intermediaries can make international money transfers “a blatant rip-off,” in the blunt assessment by … Continue reading “CurrencyFair Rides Irish Fintech Wave With Money Transfer Market”
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug
There are tough targets in drug development, and then there’s p53. It’s a holy grail, of sorts, in cancer biology—a tumor suppressor protein that gets shut down in some form in every known type of cancer. Yet every company that’s tried to protect it with a drug has failed for one reason or another. Over … Continue reading “Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug”
Gtxcel Secures $1,912,127 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=037d3089-ef91-470e-b18a-1b9560696b9b Date 10/29/2014 Company Name Gtxcel Mailing Address 144 Turnpike Rd. Southborough, MA 01772 USA Company Description The GTxcel team and suite of services work together to build publishing brands and create new revenue streams. The GTxcel brand signifies quality solutions and products. Website http://www.gtxcel.com Transaction Type Venture Equity Transaction Amount $1,912,127 … Continue reading “Gtxcel Secures $1,912,127 New Funding”
ANDalyze Receives $600,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d53c8d93-c971-4d62-9472-41c18b3ef64f Date 10/29/2014 Company Name ANDalyze Mailing Address 800 Boylston Street 16th Floor Boston, MA 02199 USA Company Description ANDalyze offers products for testing water contamination using catalytic DNA technologies. The company has developed a methodology for detecting and quantifying chemical levels based on the recent discovery of the catalytic properties of … Continue reading “ANDalyze Receives $600,000 New Funding”
Aileron Therapeutics Secures $33,000,000 Series E Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=52440910-1047-4ff1-8e08-8b5aff2115b6 Date 10/29/2014 Company Name Aileron Therapeutics Mailing Address 281 Albany St. Cambridge, MA 02139 USA Company Description Aileron Therapeutics is an emerging biopharmaceutical company that is applying its proprietary cell permeable peptide technology to generate breakthrough therapeuticsfor the treatment of cancer and other diseases. Website http://www.aileronrx.com Transaction Type Venture Equity Transaction … Continue reading “Aileron Therapeutics Secures $33,000,000 Series E Funding”
Podimetrics Obtains $1,200,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f8faa56b-d147-433f-bd09-a435a6fcaaa8 Date 10/29/2014 Company Name Podimetrics Mailing Address 205 Walden Street Cambridge, MA 02140 USA Company Description Of the 26 million diabetics in the U.S., more than a million will develop foot ulcers each year due to reduced feeling from peripheral neuropathy. Many of these patients will acquire intractable infections and 92,000 … Continue reading “Podimetrics Obtains $1,200,000 New Round”
Bio Venture Specialists Advent Raise $235M For European, U.S. Deals
Another early-stage biotech investor has clocked in with a new fund. London-based Advent Life Sciences said Tuesday it has closed a $235 million vehicle, its second specialized fund since the tech and life science investors of Advent Venture Partners went separate ways last decade. The firm used to invest in tech and life sciences from … Continue reading “Bio Venture Specialists Advent Raise $235M For European, U.S. Deals”
Who Knew? Fun Facts About Boston Innovators—the Slide Show
They fly. They sing. They build. They race. They played professional basketball, were nationally ranked fencers and rock climbers. They perform on stage with Yo-Yo Ma, and collect America’s Cup yachts. It’s no surprise that the entrepreneurs, CEOs, angels, VCs, inventors, and other members of the Boston innovation community Xconomy covers every day are pretty … Continue reading “Who Knew? Fun Facts About Boston Innovators—the Slide Show”
Another Mega Battery Factory in U.S., This One For the Grid
A stealth Swiss startup called Alevo plans to make the equivalent of Tesla Motors’ “gigafactory” in North Carolina. The main difference: its batteries will be as big as shipping containers and connect to power plants, rather than electric cars. These new batteries, designed to store energy for use in the power grid, would be built … Continue reading “Another Mega Battery Factory in U.S., This One For the Grid”
More Drama for Sarepta as FDA Delays Duchenne Drug, Shares Tank
It wasn’t too long ago that Sarepta Therapeutics (NASDAQ: [[ticker:SRPT]]) was one of the darlings of biotech. Holding a drug with very promising results—albeit in a small sample size—for a crippling disorder with no cure, the Cambridge, MA-based biotech zoomed up the stock charts. The past year, however, has been a humbling one for Sarepta … Continue reading “More Drama for Sarepta as FDA Delays Duchenne Drug, Shares Tank”
Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials
The backers of Syros Pharmaceuticals are sparing no expense. The Watertown, MA-based biotech has reeled in a $53 million Series B round, a huge sum for a company based on relatively new understanding of fundamental human biology: the way our genes are controlled by extremely complicated signals within our cells. “Our investors and board said … Continue reading “Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials”
On a Wing and a Prayer: 300,000 Angels in Search of a Unicorn
As co-founder and managing partner of San Diego’s TVC Capital, I awake every morning to a certain routine that includes scanning my Term Sheet e-mail to see what investments and acquisitions got done in the tech space. I have noticed in recent years that the space Dan Primack has devoted to investments is long, while … Continue reading “On a Wing and a Prayer: 300,000 Angels in Search of a Unicorn”
Harvest Power Obtains $20,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ab0672f6-ea6e-4b41-b379-234554e2c548 Date 10/27/2014 Company Name Harvest Power Mailing Address 221 Crescent St. Waltham, MA 02453 USA Company Description Harvest’s superpowered products and capabilities give us the opportunity to create a new life-cycle for organics. We assist communities with source separation programs, build renewable energy facilities and utilize our best-in-class technologies to produce … Continue reading “Harvest Power Obtains $20,000,000 New Financing”
Visible Measures Secures $6,975,060 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ca11ad27-0e78-443c-9c33-7ce5dcba5a01 Date 10/27/2014 Company Name Visible Measures Mailing Address 143 South Street 5th Floor Boston, MA 02111 USA Company Description Visible Measures Corp. (VMC) is helping to revolutionize the way publishers, advertisers, and audiences engage with Internet delivered video. Website http://www.visiblemeasures.com Transaction Type Venture Equity Transaction Amount $6,975,060 Transaction Round Undisclosed Proceeds … Continue reading “Visible Measures Secures $6,975,060 New Financing Round”
Minerva Biotechnologies Obtains $2,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=456559f5-446a-4fb9-93bb-a68f788b7f78 Date 10/27/2014 Company Name Minerva Biotechnologies Mailing Address 40 Bear Hill Road Waltham, MA 02451 USA Company Description The company develops drugs and stem cell technology through nanotechnology. Website http://www.minervabio.com Transaction Type Venture Equity Transaction Amount $2,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. Contact … Continue reading “Minerva Biotechnologies Obtains $2,000,000 New Funding”
Queralt Garners $2,206,959 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bd7b5179-bbd5-49ca-9549-bf55ef7237d3 Date 10/27/2014 Company Name Queralt Mailing Address 250 State Street North Haven, CT 06473 USA Company Description Using Queralt’s iQ3 Asset Tracking System, information about critical organizational assets is only a mouse-click away. Our iQ3 Asset Tracking Systems feature a real-time dashboard, a powerful analytics engine, and user-configurable notifications and alerts, … Continue reading “Queralt Garners $2,206,959 New Financing”
Quartet Medicine Lands $17,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c6876be1-7230-46eb-bc96-ca1410f1022a Date 10/27/2014 Company Name Quartet Medicine Mailing Address Undisclosed Cambridge, MA 02139 USA Company Description Quartet Medicine is a private, biotechnology company focused on discovering and developing novel treatments for chronic pain and inflammation. Human genetics and preclinical target validation data point to increased tetrahydrobiopterin (BH4) as a critical mediator of … Continue reading “Quartet Medicine Lands $17,000,000 Series A Round”
Syros Pharmaceuticals Obtains $53,149,996 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0546dddc-4442-4227-9a82-f46086eb06d9 Date 10/27/2014 Company Name Syros Pharmaceuticals Mailing Address 480 Arsenal Street Watertown, MA 02472 USA Company Description Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and … Continue reading “Syros Pharmaceuticals Obtains $53,149,996 New Funding”
Credorax Garners $40,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=872b9dab-f172-487c-9579-c81fe0e1bc16 Date 10/27/2014 Company Name Credorax Mailing Address 106 Southville Road Southborough, MA 01772 USA Company Description Credorax provides online payment processing & acquiring bank services under one roof, to a diverse range of online merchants worldwide. Website http://www.credorax.com Transaction Type Venture Equity Transaction Amount $40,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “Credorax Garners $40,000,000 New Financing Round”
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More
Deal flow is in full swing on the East Coast. At least three life sciences startups launched out of Boston and New York this week, with a few other firms filling up their bank accounts with either new funding rounds or partnership deals. Those stories and plenty more below: —Boston-based PureTech raised $55 million from … Continue reading “East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More”
Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet
Celgene, one of biopharma’s most aggressive and creative dealmakers, said Thursday it has forged a deep partnership with South San Francisco, CA-based Sutro Biopharma that could end up with an acquisition. If it does, it would dramatically expand Celgene’s footprint into the world of biologics, which the Summit, NJ-based company has mainly stayed away from … Continue reading “Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet”
Innovation Hub: A Genetically Modified Menu
People have been cross-breeding their food for thousands of years—but modifying food in a lab is still relatively new and has ignited serious controversy. We recently talked with New York Times science reporter Amy Harmon and genetics professor Pamela Ronald about the opportunities presented by genetically modified foods, and the myths that surround them. (This interview … Continue reading “Innovation Hub: A Genetically Modified Menu”
Grid-Scale Energy Storage: Is the Price Finally Right?
The high cost of batteries has made them impractical for storing energy from wind and solar or providing back-up power on the electricity grid. Now, though, several battery startups are claiming price reductions that make energy storage on the grid look more feasible. Fremont, CA-based Imergy Power Systems today said it’s developed a shipping container-size … Continue reading “Grid-Scale Energy Storage: Is the Price Finally Right?”
New Atlas Startup Gets “Quartet” of Backers, $17M For Pain Drugs
It’s notoriously difficult to develop drugs for pain, in part because the results from animal tests rarely hold up in human studies. Still, a new startup from Atlas Venture called Quartet Medicine will to try to navigate the minefield, buoyed by new insights it believes can help connect the dots between animals and humans. Cambridge, … Continue reading “New Atlas Startup Gets “Quartet” of Backers, $17M For Pain Drugs”
Why Cleantech Investing Has Morphed Into Energy and Sustainability
Advocates of cleantech investing often make the case that there are enormous opportunities to make the world cleaner and more sustainable. But what if labeling yourself a cleantech investor or entrepreneur is actually limiting? That’s the question I walked away with after a panel of venture investors at the Energy Symposium at the Harvard Business … Continue reading “Why Cleantech Investing Has Morphed Into Energy and Sustainability”
Fortress Risk Management Obtains $3,500,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e12e6267-636e-435d-bbc2-3ee56f96b610 Date 10/23/2014 Company Name Fortress Risk Management Mailing Address 35 Paddock Lane South Glastonbury, CT 06073 USA Company Description Fortress Risk Management was founded in 2010 and is headquartered in Wethersfield, CT. We provide Enterprise Risk Management solutions to community financial institutions both via cloud and in-house installations. Website http://www.fortresserm.com Transaction … Continue reading “Fortress Risk Management Obtains $3,500,000 New Funding Round”
Nano Terra Obtains $6,388,098 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1ba6d654-c0ec-4a9d-8cd5-bfec29d91bf5 Date 10/23/2014 Company Name Nano Terra Mailing Address 737 Concord Ave. Cambridge, MA 02138 USA Company Description Nano Terra develops and commercializes transformational products using our expertise in surface science, printing and patterning, advanced materials, chemistry and polymers, rapid prototyping, and engineering and modeling. Website http://www.nanoterra.com Transaction Type Venture Equity Transaction … Continue reading “Nano Terra Obtains $6,388,098 New Financing Round”
Medrobotics Garners $20,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cd94a216-2b9d-4348-b685-d9397d6c3344 Date 10/23/2014 Company Name Medrobotics Mailing Address 475 Paramount Drive Raynham, MA 02767 USA Company Description Medrobotics has exclusive worldwide licenses for its technologies from Carnegie Mellon University and the University of Pittsburgh as well as additional robust development of its own intellectual property portfolio. The Company has an operational facility … Continue reading “Medrobotics Garners $20,000,000 New Funding”
Ello Obtains $5,500,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=357670c6-8503-4516-9019-ed99a1966add Date 10/23/2014 Company Name Ello Mailing Address 47 Maple Street Burlington, VT 05401 USA Company Description Ello is a simple, beautiful, and ad-free social network created by a small group of artists and designers. Website http://www.ello.co Transaction Type Venture Equity Transaction Amount $5,500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “Ello Obtains $5,500,000 New Funding Round”
The 10th Annual Personalized Medicine Conference
The Personalized Medicine Conference is an annual two-day conference that is considered the most prestigious event in the field. The conference attracts more than 600 national and international thought leaders across multiple disciplines. It is co-hosted and presented by Partners HealthCare Personalized Medicine, Harvard Business School, and Harvard Medical School in association with the American … Continue reading “The 10th Annual Personalized Medicine Conference”
Brown University and the Future of Virtual Reality
While conceived in the 1960s, the heyday of virtual reality didn’t set in until the ‘80s and ‘90s with the appearance of popular movies like “Tron” and “Lawnmower Man,” and gaming innovations such as SEGA’s VR headset and “Virtuality” arcade games. There’s a chance that you don’t remember any of that, however, and nobody could … Continue reading “Brown University and the Future of Virtual Reality”
Actavis Nabs Option to Buy Rhythm Pharma’s GI Drug For Diabetics
[Updated, 10/23/14, 4:41 pm ET] Rhythm Pharmaceuticals hinted that a strategic move was coming when a drug it’s been developing for diabetic gastroparesis cleared a key clinical hurdle earlier this year. That came to fruition today, because Actavis has stepped and offered Rhythm a financial payday if that drug can make it to the finish … Continue reading “Actavis Nabs Option to Buy Rhythm Pharma’s GI Drug For Diabetics”
In Wake of Dot-com Bust, Blueport Commerce Makes Furniture.com Work
[Updated at 3:10 with a correction to revenue numbers provided.] Carl Prindle’s mission during the dot-com boom was to disrupt furniture companies. Now, he’s trying to help them sell their goods online. As the CEO of Boston-based Blueport Commerce, Prindle has launched an e-commerce software company and revived the Furniture.com website by melding e-commerce with brick-and-mortar … Continue reading “In Wake of Dot-com Bust, Blueport Commerce Makes Furniture.com Work”
Proteon Cuts Price, Boosts Shares to Bag $61M in IPO
Proteon Therapeutics is about to successfully pivot from a potential portfolio company of Novartis to a publicly traded entity—just not with the valuation it was hoping for. Waltham, MA-based Proteon priced its IPO late Tuesday at $10 per share. The company sold 6,110,000 shares of stock to investors, raising $61.1 million before discounts due to … Continue reading “Proteon Cuts Price, Boosts Shares to Bag $61M in IPO”
As Atlas Splits, Is There A Case To Make In Venture For Specialists?
Readers of this column who are of a certain age might remember Chrissie Hynde of the Pretenders in black eyeliner, dressed as a diner waitress singing, “I’m special, so special, and I gotta have some of your attention.” Swap “money” for “attention,” and it could be a refrain that venture capitalists are singing these days … Continue reading “As Atlas Splits, Is There A Case To Make In Venture For Specialists?”
Robots That Are Ready to Work, in Pictures
Even roboticists still debate exactly what a robot is. Is it a computer that moves, or a machine that can operate autonomously in reaction to its environment? What can be said for sure is that robotics is a set of technologies, often used for automation, and that humanoid robots are just one of many forms … Continue reading “Robots That Are Ready to Work, in Pictures”
Unum Therapeutics Lands $12,000,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e31f7a52-dcef-447e-a90c-b65df9bb0eb3 Date 10/22/2014 Company Name Unum Therapeutics Mailing Address One Broadway 4th Floor Cambridge, MA 02142 USA Company Description Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Website http://www.unumrx.com Transaction Type Venture Equity Transaction Amount $12,000,000 Transaction Round … Continue reading “Unum Therapeutics Lands $12,000,000 Series A Funding”
Security Software Provider SilverSky Snapped Up by BAE Systems
SilverSky, a Milford, CT-based provider of cloud-based managed services and security software, said Tuesday it agreed to be acquired for $232.5 million by Britain’s BAE Systems and become part of the larger company’s applied intelligence division. SilverSky has offices in Boston, New York, Denver, Colorado Springs, CO, and Morrisville, NC, as well as in Florida … Continue reading “Security Software Provider SilverSky Snapped Up by BAE Systems”
Sanofi-Genzyme Joins $12M Round for T-Cell Therapy Startup, Unum
It’s no secret that cancer immunotherapy is exploding. The pharma and biotech world is abuzz trying to find the best ways to harness the power of the immune system to fight cancer. Startups are getting in on the act, too—like a new Cambridge, MA-based company, Unum Therapeutics, that just came out of the woodwork today … Continue reading “Sanofi-Genzyme Joins $12M Round for T-Cell Therapy Startup, Unum”
John Maeda on PopTech and VC Life: “Conferences Are the New College”
The 18th annual PopTech conference starts this Thursday in Camden, ME, and design luminary John Maeda is psyched. Maeda organized this year’s gathering of innovators, artists, and scientists. He’s a technologist and recovering academic who recently dived into the world of venture capital. Maeda joined VC firm Kleiner Perkins Caufield & Byers as “design partner” … Continue reading “John Maeda on PopTech and VC Life: “Conferences Are the New College””
Boston’s Life Science Disruptors: The Photos
How do you pull off a successful biotech IPO? With patience, preparation, and no fear of failure. Last week, I recapped our latest biotech event, “Boston’s Life Science Disruptors.” Attendees at the Novartis Institutes for Biomedical Research got a behind-the-scenes look at the ups and downs faced by three local biotechs—Zafgen, Epizyme, and Sage Therapeutics—on … Continue reading “Boston’s Life Science Disruptors: The Photos”
Benu Networks Obtains $27,700,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea629180-dd1c-437f-9e57-1b99420fed3c Date 10/21/2014 Company Name Benu Networks Mailing Address 300 Concord Road Billerica, MA 01821 USA Company Description Benu Networks is a Boston Area Startup Company focused on delivering next generation Networking and Wireless Communication products. Website http://www.benu.net Transaction Type Venture Equity Transaction Amount $27,700,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes … Continue reading “Benu Networks Obtains $27,700,000 New Funding Round”
Saylent Technologies Receives $2,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=47542bc8-56b6-478a-9ec4-478a1a53550d Date 10/21/2014 Company Name Saylent Technologies Mailing Address 500 Franklin Village Drive Franklin, MA 02038 USA Company Description Saylent Technologies is a leading provider of debit card management solutions for the banking, credit union and payment industries. Saylent’s product, Y-Debit, is a dynamic management suite to increase debit card revenue for … Continue reading “Saylent Technologies Receives $2,000,000 New Financing”
PureTech Secures $55,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d118f20-8718-4b98-aa38-6fc9aac205c0 Date 10/21/2014 Company Name PureTech Mailing Address 500 Boylston Street Boston, MA 02116 USA Company Description Our senior partners and team have directly driven the launch & FDA approval of over 100 drugs and devices. Our team of game designers has collectively shipped over 15 consumer games, including the critically-acclaimed Medal … Continue reading “PureTech Secures $55,000,000 New Round”
Fiksu Receives $10,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7b188c8b-7de7-41bf-b6e5-ab8dfa00f6da Date 10/21/2014 Company Name Fiksu Mailing Address 31 St. James Avenue Boston, MA 02116 USA Company Description We’re a team of entrepreneurial mathematicians, technologists, and online marketing veterans. We’ve pooled our smarts to create a platform for helping mobile app brands achieve their business goals faster and more cost effectively than … Continue reading “Fiksu Receives $10,000,000 New Round”
Cazena Garners $8,000,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ec22e29c-bc7a-4508-aedd-f7983328fd56 Date 10/21/2014 Company Name Cazena Mailing Address 26 Canterbury Hill Rd. Acton, MA 01720 USA Company Description Cazena was founded with a mission to radically simplify and speed up access to big data, allowing much faster business outcomes at a fraction of the cost. Cazena is backed by Andreessen Horowitz and … Continue reading “Cazena Garners $8,000,000 Series A Funding”
Cubist CEO Bonney Steps Down After 12-Year Stint
Mike Bonney has seen Cubist Pharmaceuticals (NASDAQ: [[ticker:CBST]]) build an unlikely narrative, rising from an antibiotics startup without a marketed product to a mid-cap biotech with the bank account to buy other nascent companies. Today, more than a decade into that work, Bonney is stepping aside. Bonney will officially step down from his post on … Continue reading “Cubist CEO Bonney Steps Down After 12-Year Stint”
With Invesco’s Support, PureTech Boosts Power to Back Startups
PureTech has always been tough to define. Though it was originally called PureTech Ventures, the Boston company isn’t a venture firm. Rather, it seeks out cost-efficient ways to create innovative life sciences startups in-house, instead of finding nascent companies and investing in them with others. It doesn’t raise the massive funds that a venture firm … Continue reading “With Invesco’s Support, PureTech Boosts Power to Back Startups”